Author:
Elkartouti A.,Hachimi M. A.,Lamjareb C.,Tabache F.,Lezrek M.,Tarib A.,Rguibi M.,Cherrah Y.
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Blay JY, Le Cesne A, Alberti L, Ray-Coquard I (2005) Targeted cancer therapies. Bull Cancer 92(2):E13–E18
2. Blay JY (2007) Thérapeutiques antiangiogéniques des tumeurs solides. Rev Med Int 28:S7–S8
3. Tannock F, Evans WK (1985) Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinoma. Cancer Treat Rep 69:227–228
4. Schaffer P, Jambert C, Bollack C (1991) Épidémiologie des cancers urologiques. In: Steg A, Eschwege F (eds). Flammarion-Mé decine-Sciences, Paris, pp 1–31
5. Dekernion JB, Rammin KP, Smith RB (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120:148–152